Cardiac tamponade as a form of presentation of pericardial metastasis
Keywords:
cancer, malignant pericardial effusion, secondary cardiac tumorAbstract
A descriptive, retrospective and longitudinal study was carried out in order to characterize aspects of interest in patients with cardiac tamponade discharge from the intensive care unit of the "Dr. Agostinho Neto de Guantanamo during the period 2010 - 2016. This condition may be the presentation of pericardial metastasis of different neoplasms. The following variables were studied: age, sex, discharge status, complementary studies, diagnoses and applied treatment. The age of the patients was 66.5 ± 10.1 years; the male sex predominated and all were deceased. Hemochemistry, transthoracic echocardiography, pericardiocentesis, study of pericardial fluid (cytochemical, cytological and bacteriological) chest x-ray were performed. The most common causes were neoplasia of the lung and breast. Cardiac tamponade is expressed as a form of presentation of malignant pericardial effusions. For that, the assessment should be taken into account in a patient in critical condition due to a large pericardial effusion.
Downloads
Download data is not yet available.
References
1. Cosyns B, Plein S, Nihoyanopoulos P, Smiseth O, Achenbach S, Andrade MJ, et al. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging. 2014; 16:12–31.
2. Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015; 101:1159–68.
3. Zylberman M, Pupareli C, Rosales A, Rosemberg M, Santos D, Gastaldello N, Patané AK.Utilidad del cisplatino intrapericárdico en el tratamiento del derrame pericárdico maligno. Rev Arg cardiol. 2010;78(2):28-36.
4. Karatolios K, Pankuweit S. Diagnostic value of biochemical biomarkers in malignant pericardial effusion. Heart Fail Rev. 2013; 18:337–44.
5. PawlakCies´lik A, Szturmowicz M, Fijałkowska A, Ga˛tarek J, Gralec R, Błasin´ ska-Przerwa K, et al. Diagnosis of malignant pericarditis: a single centre experience. Kardiol Pol. 2012;70: 1147–53.
6. Smits AJ, Kummer JA, Hinrichs JW, Herder GJ, Scheidel-Jacobse KC, Jiwa NM, et al. EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma. Cell Oncol. 2012;35:189–96.
7. Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R. Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J. 2012; 23:1625–31.
8. Patel N, Rafique AM, Eshaghian S, Mendoza F, Biner S, Cercek B, Siegel RJ. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol. 2013; 112:1235–9.
9. Patel N, Rafique AM, Eshaghian S, Mendoza F, Biner S, Cercek B, Siegel RJ. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol. 2013;112:1235–9.
10. Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8.
11. Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento. Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio. Rev Esp Cardiol [Internet]. 2015 [citado 5 Feb 2017]; 68 (12):1168-74. Disponible en: http://dx.doi.org/10.1016/j.recesp.2015.11.002
12. Lobert P, Brown RK, Dvorak RA, Corbett JR, Kazerooni E A, Wong KK. Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT. Clin Radiol. 2013; 68:e59–e71.
13. James OG, Christensen JD, Borges-Neto S, Koweek LM. Utility of FDG PET/CT in inflammatory cardiovascular disease. Radio Graphics. 2011; 31:1271–86.
14. Ristic AD, Pankuweit S, Maksimovic R. Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev. 2013; 18:345–53.
15. Ristic´ AD, Imazio M, Adler Y, Anastasakis A, Badano LP, Brucato A, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014; 35:2279–84.
16. Frohlich GM, Keller P, Schmid F, Wolfrum M, Osranek M, Falk C, et al. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur Heart J. 2013; 34:1414–23.
17. Imazio M, Mayosi BM, Brucato A, Markel GR. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010; 11:928–35.
18. Lestuzzi C, Bearz A, Lafaras C, Gralec R, Cervesato E, Tomkowski W, et al. Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer. 2011;72:340–7.
2. Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015; 101:1159–68.
3. Zylberman M, Pupareli C, Rosales A, Rosemberg M, Santos D, Gastaldello N, Patané AK.Utilidad del cisplatino intrapericárdico en el tratamiento del derrame pericárdico maligno. Rev Arg cardiol. 2010;78(2):28-36.
4. Karatolios K, Pankuweit S. Diagnostic value of biochemical biomarkers in malignant pericardial effusion. Heart Fail Rev. 2013; 18:337–44.
5. PawlakCies´lik A, Szturmowicz M, Fijałkowska A, Ga˛tarek J, Gralec R, Błasin´ ska-Przerwa K, et al. Diagnosis of malignant pericarditis: a single centre experience. Kardiol Pol. 2012;70: 1147–53.
6. Smits AJ, Kummer JA, Hinrichs JW, Herder GJ, Scheidel-Jacobse KC, Jiwa NM, et al. EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma. Cell Oncol. 2012;35:189–96.
7. Maisch B, Ristic AD, Pankuweit S, Neubauer A, Moll R. Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J. 2012; 23:1625–31.
8. Patel N, Rafique AM, Eshaghian S, Mendoza F, Biner S, Cercek B, Siegel RJ. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol. 2013; 112:1235–9.
9. Patel N, Rafique AM, Eshaghian S, Mendoza F, Biner S, Cercek B, Siegel RJ. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol. 2013;112:1235–9.
10. Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8.
11. Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento. Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio. Rev Esp Cardiol [Internet]. 2015 [citado 5 Feb 2017]; 68 (12):1168-74. Disponible en: http://dx.doi.org/10.1016/j.recesp.2015.11.002
12. Lobert P, Brown RK, Dvorak RA, Corbett JR, Kazerooni E A, Wong KK. Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT. Clin Radiol. 2013; 68:e59–e71.
13. James OG, Christensen JD, Borges-Neto S, Koweek LM. Utility of FDG PET/CT in inflammatory cardiovascular disease. Radio Graphics. 2011; 31:1271–86.
14. Ristic AD, Pankuweit S, Maksimovic R. Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis. Heart Fail Rev. 2013; 18:345–53.
15. Ristic´ AD, Imazio M, Adler Y, Anastasakis A, Badano LP, Brucato A, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014; 35:2279–84.
16. Frohlich GM, Keller P, Schmid F, Wolfrum M, Osranek M, Falk C, et al. Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. Eur Heart J. 2013; 34:1414–23.
17. Imazio M, Mayosi BM, Brucato A, Markel GR. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010; 11:928–35.
18. Lestuzzi C, Bearz A, Lafaras C, Gralec R, Cervesato E, Tomkowski W, et al. Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer. 2011;72:340–7.
How to Cite
1.
González Hechavarría JA, Estevan Soto JA, Elias Sierra R, Elias Armas KS, Bordelois Abdo MS. Cardiac tamponade as a form of presentation of pericardial metastasis. Rev Inf Cient [Internet]. 2018 Jan. 16 [cited 2025 Apr. 15];97(1):137-45. Available from: https://revinfcientifica.sld.cu/index.php/ric/article/view/1814
Issue
Section
Original Articles
